Eric L. Dobmeier

Eric L. Dobmeier

Chief Operating Officer at Seattle Genetics, Inc.

Are you Eric L. Dobmeier? Claim your profile
 
  • IDENTIFY corporate executives in Eric L. Dobmeier's network and community.
  • FOLLOW changes in Eric L. Dobmeier's employment and money-in-motion.
  • CONNECT with Eric L. Dobmeier through your network of contacts.

Eric L. Dobmeier's Executive Work History


Current
Chief Operating Officer, Seattle Genetics, Inc.
Past
To view Eric L. Dobmeier's complete executive work history,
Education
Age
48
 
 

Eric L. Dobmeier's Biography


Eric L. Dobmeier, 48, has served as a member of our Board of Directors since April 2012. Mr. Dobmeier is currently the Chief Operating Officer of Seattle Genetics, Inc. In this role, he is responsible for Seattle Genetics' business development, manufacturing, corporate communications, program management and alliance management functions. Mr. Dobmeier joined Seattle Genetics in March 2002 and has served in positions of increasing responsibility since then, most recently as Chief Business Officer from May 2007 to June 2011. Prior to joining Seattle Genetics, Mr. Dobmeier was with the law firms of Venture Law Group and Heller Ehrman LLP where he ...

(Read More)

Source: Stemline Therapeutics, Inc. on 04/05/2017

 

By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Eric L. Dobmeier. More specifically, you'll be able to:

  • IDENTIFY corporate executives in Eric L. Dobmeier's network and community.
  • FOLLOW changes in Eric L. Dobmeier's employment and money-in-motion.
  • CONNECT with Eric L. Dobmeier through your network of conections.
 

Search for over 360,000 executive profiles.

/bio

Example: Eric L. Dobmeier

Eric L. Dobmeier's Connections (66)


Chairman of the Board, Ocera Therapeutics, Inc.
Chief Technical Officer, Seattle Genetics, Inc.
Chief Medical Officer and Executive Vice President, Research and Development, Seattle Genetics, Inc.
Dir., President and Chief Executive Officer, TetraLogic Pharmaceuticals Corporation
Chief Financial Officer, Seattle Genetics, Inc.
Dir., President and Chief Executive Officer, Relypsa, Inc.